[1] JINEK M, EAST A, CHENG A, LIN S, MA E, DOUDNA J. RNA-programmed genome editing in human cells. Elife, 2013, 2: e00471.
[2] CONG L, RAN F A, COX D, LIN S L, BARRETTO R, HABIB N, HSU P D, WU X B, JIANG W Y, MARRAFFINI L A. Multiplex genome engineering using CRISPR/Cas systems. Science, 2013, 339(6121): 819-823.
[3] MALI P, YANG L H, ESVELT K M, AACH J, GUELL M, DICARLO J E, NORVILLE J E, CHURCH G M. RNA-guided human genome engineering via Cas9. Science, 2013, 339(6121): 823-826.
[4] KIM B C, KIM H R, KIM M Y, PARK C S, JIN D I. Analysis of transgene integration efficiency into porcine fetal fibroblast using different transfection methods. Reproductive & Developmental Biology, 2008, 33: 113-117.
[5] DENNING C, DICKINSON P, BURL S, WYLIE D, FLETCHER J, CLARK AJ. Gene targeting in primary fetal fibroblasts from sheep and pig. Cloning Stem Cells, 2001, 3(4): 221-231.
[6] DENNING W, DAS S, GUO S, XU J, KAPPES J C, HEL Z. Optimization of the transductional efficiency of lentiviral vectors: effect of sera and polycations. molecular biotechnology, 2013, 53(3): 308-314.
[7] HELDIN C H, MIYAZONO K, TEN DIJKE P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature, 1997, 390(6659): 465-471.
[8] Liu G, Liu K, Wei H, Li L, Zhang S. Generation of porcine fetal fibroblasts expressing the tetracycline-inducible Cas9 gene by somatic cell nuclear transfer. Molecular Medicine Reports, 2016, 14(3): 2527-2533
[9] LAI S S, WEI S, ZHAO B T, OUYANG Z, ZHANG Q J, FAN N N, LIU Z M, ZHAO Y, YAN Q M, ZHOU X Q, LI L, XIN J G, ZENG Y Z, LAI L X, ZOU Q J. Generation of knock-in pigs carrying Oct4-tdTomato reporter through CRISPR/Cas9-mediated genome engineering. PLoS One. 2016, 11(1): e0146562.
[10] YOON B S, POGUE R, OVCHINNIKOV D A, YOSHII I, MISHINA Y, BEHRINGER R R, LYONS K M. BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways. Development, 2006, 133(23): 4667-4678.
[11] YUJI H, JUNKO H, YURIKO, M, YURIKO M, KYOKO O, EICHI T, TETSUICHIRO I, YOSHIHIKO S. Growth differentiation factor 5 (GDF-5) induces matrix Metalloproteinase 2 (MMP-2) expression in periodontal ligament cells and modulates MMP-2 and MMP-13 activity in osteoblasts. Bone and Tissue Regeneration Insights, 2010(3): 1-10.
[12] BASSON M A. Signaling in cell differentiation and morphogenesis. Cold Spring Harbor Perspectives in Biology, 2012, 4(6): a008151
[13] ZHAO Y Y, LI X X, WANG W, CHEN X, YU P, WANG J J, XU Y X. Effect of BMPR-IB gene silencing by siRNA on apoptosis and steroidogenesis of porcine granulosa cells. Genetics & Molecular Research Gmr, 2014, 13(4): 9964-9975.
[14] WILSON T, WU X Y, JUENGEL J L, ROSS I K, LUMSDEN J M, LORD E A, DODDS K G, WALLING G A, MCEWAN J C, O'CONNELL A R, MCNATTY K P, MONTGOMERY G W. Highly prolific Booroola sheep have a mutation in the intracellular kinase domain of bone morphogenetic protein IB receptor (ALK-6) that is expressed in both oocytes and granulosa cells. Biology of Reproduction, 2001, 64(4): 1225-1235.
[15] MULSANT P, LECERF F, FABRE S, SCHIBLER L, MONGET P, LANNELUC I, PISSELET C, RIQUET J, MONNIAUX D, CALLEBAUT I, CRIBIU E, THIMONIER J, TEYSSIER J, BODIN L, COGNIÉ Y, CHITOUR N, ELSEN J M. Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola Merino ewes. Proceedings of the National Academy of Sciences of the United States of America, 2001, 98(9): 5104-5109.
[16] SOUZA C J, MACDOUGALL C, MACDOUGALL C, CAMPBELL B K, MCNEILLY A S, BAIRD D T. The Booroola (FecB) phenotype is associated with a mutation in the bone morphogenetic receptor type 1 B (BMPR1B) gene. Journal of Endocrinology, 2001, 169(2): R1-R6.
[17] LIVAK K J, SCHMITTGEN T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 2001, 25(4): 402-408.
[18] GRAHAM D B, ROOT D E. Resources for the design of CRISPR gene editing experiments. Genome Biology, 2015, 16(1): 260-281.
[19] DUAN J, LU G, XIE Z, LOU M, LUO J, GUO L, ZHANG Y. Genome-wide identification of CRISPR/Cas9 off-targets in human genome. Cell Research, 2014, 24(8): 1009-1012.
[20] BULTMANN S, MORBITZER R, SCHMIDT C S, THANISCH K, SPADA F, ELSAESSER J, LAHAYE T, LEONHARDT H. Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acids Research, 2012, 40(12): 5368-5377.
[21] HSU P D, SCOTT D A, WEINSTEIN J A, RAN F A, KONERMANN S, AGARWALA V, LI Y, FINE E J, WU X, SHALEM O, CRADICK T J, MARRAFFINI L A, BAO G, ZHANG F. DNA targeting specificity of RNA-guided Cas9 nucleases. Nature Biotechnology, 2013, 31(9): 827-832.
[22] KUSCU C, ARSLAN S, SINGH R, THORPE J, ADLI M. Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nature Biotechnology, 2014, 32(7): 677-683.
[23] TSAI S Q, ZHENG Z, NGUYEN N T, LIEBERS M, TOPKAR V V, THAPAR V, WYVEKENS N, KHAYTER C, IAFRATE A J, LE L P, ARYEE M J, JOUNG J K. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nature Biotechnology, 2015, 33(2): 187-197.
[24] WANG X, WANG Y, WU X, WANG J, WANG Y, QIU Z, CHANG T, HUANG H, LIN R J, YEE J K. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nature Biotechnology, 2015, 33(2): 175-178.
[25] KIM D, BAE S, PARK J, KIM E, KIM S, YU H R, HWANG J, KIM J I, KIM J S. Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nature Methods, 2015, 12(3): 237-244.
[26] KOCHUPURAKKAL B S, IGLEHART J D. Nourseothricin N-acetyl transferase: a positive selection marker for mammalian cells. PloS one, 2013, 8(7): e68509.
[27] WATANABE S, IWAMOTO M, SUZUKI S, FUCHIMOTO D, HONMA D, NAGAI T, HASHIMOTO M, YAZAKI S, SATO M, ONISHI A. A novel method for the production of transgenic cloned pigs: electroporation-mediated gene transfer to non-cultured cells and subsequent selection with puromycin. Biology of reproduction, 2005, 72(2): 309-315.
[28] HOTTA A, CHEUNG A Y, FARRA N, GARCHA K, CHANG W Y, PASCERI P, STANFORD W L, ELLIS J. EOS lentiviral vector selection system for human induced pluripotent stem cells. Nature Protocols, 2009, 4(12): 1828-1844.
[29] SPENCER A. Enhancing Lentiviral Transduction Efficiency[A]. Sigma-aldrich, 2011.
[30] WILSON A A, MURPHY G J, HAMAKAWA H, KWOK L W, SRINIVASAN S, HOVAV A H, MULLIGAN R C, AMAR S, SUKI B, KOTTON D N. Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages. Journal of Clinical Investigation, 2010, 120(1): 379-389.
[31] FISHMAN D D, SEGAL S, LIVNEH E. The role of protein kinase C in G1 and G2/M phases of the cell cycle (review). International journal of oncology, 1998, 12: 181-186.
[32] LONG X E, GONG Z H, PAN L, Zhong Z W, Le Y P, Liu Q, Guo J M, Zhong J C. Suppression of CDK2 expression by siRNA induces cell cycle arrest and cell proliferation inhibition in human cancer cells. BMB reports, 2010, 43: 291-296. |